US31573L1052 - Common Stock
FIBROBIOLOGICS INC
NASDAQ:FBLG (7/5/2024, 7:00:02 PM)
After market: 4.69 -0.24 (-4.87%)4.93
+0.7 (+16.55%)
Fibrobiologics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Houston, Texas. The company went IPO on 2024-01-31. FibroBiologics, Inc. is a cell therapy regenerative medicine company. The firm is focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal. Its product candidates include CybroCell, CYMS101 and CYWC628. CybroCell is an allogeneic fibroblast cell-based therapy for degenerative disc disease. This technology is being designed as an alternative method for repairing the cartilage of the intervertebral disc (or any other articular cartilage). The firm is developing CYMS101 as an allogeneic fibroblast cell-based therapy to treat Multiple sclerosis (MS) and has completed the Phase I study. The firm is developing CYWC628 as an allogeneic fibroblast cell-based therapy for wound healing.
FIBROBIOLOGICS INC
455 E. Medical Center Blvd, Suite 300
Houston TEXAS
P: 12816715152
Employees: 0
Website: https://fibrobiologics.com/
HOUSTON, June 25, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) (
Friday's session: top gainers and losers
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
HOUSTON, June 13, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) (
Here you can normally see the latest stock twits on FBLG, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: